[A new oral iron preparation with a new concept].
Within the framework of a clinical study in 30 female patients suffering from concealed and manifest iron deficiency, Tardyferon--a progressive iron preparation based upon two synergistic active principles--demonstrated its superiority especially with regard to its excellent tolerance which is so important in the treatment of such disorders. Apart from the depot effect ensuring an optimal absorption rate, the mucoproteose which promotes bioavailability by protecting the mucosa against iron-related irritation deserves great attention.
D000284:Administration, Oral; D000747:Anemia, Hypochromic / Q000188:drug therapy; D003692:Delayed-Action Preparations; D004339:Drug Compounding; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007413:Intestinal Mucosa; D007501:Iron / Q000008:administration & dosage / Q000627:therapeutic use*; D009088:Mucoproteins / Q000302:isolation & purification
D003692:Delayed-Action Preparations; D009088:Mucoproteins; D007501:Iron
Orales Eisen-Therapeutikum mit neueum Konzept.